Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,649 | -22,681 | -14,921 | -8,399 | -11,709 |
| Depreciation Amortization | 1,911 | 1,550 | 1,272 | 719 | 3,129 |
| Income taxes - deferred | -1,239 | -178 | N/A | 0 | -7,407 |
| Accounts receivable | 294 | 51 | 125 | 26 | 2,572 |
| Other Working Capital | 1,301 | 2,019 | 1,076 | 588 | -2,085 |
| Other Operating Activity | -1,371 | 5,127 | 3,183 | 2,040 | -16,447 |
| Operating Cash Flow | $-19,753 | $-14,112 | $-9,265 | $-5,026 | $-31,947 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -41 | -22 | -16 | -10 | -358 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 3,117 |
| Other Investing Activity | 13,079 | 12,158 | 11,974 | 5,266 | 14,198 |
| Investing Cash Flow | $13,038 | $12,136 | $11,958 | $5,256 | $16,957 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -26 | -24 | -17 | -8 | -100 |
| Common Stock Issued | 5,127 | N/A | N/A | N/A | 63 |
| Common Stock Repurchased | -27 | N/A | -13 | -2 | -110 |
| Other Financing Activity | 24,791 | 25,075 | 523 | 0 | 764 |
| Financing Cash Flow | $29,865 | $25,051 | $493 | $-10 | $617 |
| Exchange Rate Effect | -63 | -36 | -38 | 73 | 70 |
| Beginning Cash Position | 10,096 | 10,096 | 10,096 | 10,096 | 24,399 |
| End Cash Position | 33,183 | 33,135 | 13,244 | 10,389 | 10,096 |
| Net Cash Flow | $23,087 | $23,039 | $3,148 | $293 | $-14,303 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,753 | -14,112 | -9,265 | -5,026 | -31,947 |
| Capital Expenditure | -64 | -40 | -16 | -10 | -440 |
| Free Cash Flow | -19,817 | -14,152 | -9,281 | -5,036 | -32,387 |